Cellular Nanosponges Could Neutralize SARS-CoV-2

  • Author: ChemistryViews.org
  • Published: 25 June 2020
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Nano Letters/ACS Publications
  • Associated Societies: American Chemical Society (ACS), USA
thumbnail image: Cellular Nanosponges Could Neutralize SARS-CoV-2

The coronavirus SARS-CoV-2 causes the current global outbreak of COVID-19. The virus has glycoprotein spikes on its surface. These spikes help SARS-CoV-2 enter host cells by binding to receptors on the surface of the host cells' membrane, such as the angiotensin-converting enzyme 2 (ACE2). Blocking these interactions could keep the virus from infecting cells. Drugs that bind to the spike protein are, thus, one approach for COVID-19 treatment and prevention. Offering the virus an entirely different target could be another promising approach to protect cells from the virus.


Anthony Griffiths, Boston University School of Medicine, MA, USA, Liangfang Zhang, University of California San Diego, La Jolla, USA, and colleagues have developed nanoparticle decoys that display the virus’ natural targets, including ACE2, on their surface. These decoys could prevent SARS-CoV-2 from entering cells by binding to it and blocking its spike proteins from further interactions. To create the nanosponges, the researchers coated a nanoparticle polymer core made from poly(lactic-co-glycolic acid) (PLGA) with cell membranes from either human lung epithelial cells or macrophages, two cell types that can be infected by SARS-CoV-2.


The team showed that the resulting nanosponges contained ACE2 and other viral receptors using Western blot analysis. When administered to mice, the nanosponges did not show any short-term toxicity. The researchers treated cells simultaneously with SARS-CoV-2 and the lung-epithelial or macrophage nanosponges in vitro. Both decoys neutralized SARS-CoV-2 and prevented it from infecting cells to a similar extent. In theory, this nanosponge approach would work even if SARS-CoV-2 mutates to resist other therapies, as long as the virus targets the same types of receptors. According to the researchers, it could also be used against other viruses.



Also of Interest

  • Collection: SARS-CoV-2 Virus
    What we know about the new coronavirus and COVID-19
  • LitCovid
    Curated literature hub for tracking up-to-date scientific information about COVID-19
  • Many publishers and other entities have signed a joint statement to ensure that COVID-19 research findings and data are shared rapidly and openly

 

 

Article Views: 535

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


Magazine of Chemistry Europe (16 European Chemical Societies)published by Wiley-VCH